估计非酒精性脂肪肝炎健康状况的效用值:一个离散选择实验
Daniel Aggio1, Katy Gallop1, Villum Wittrup-Jensen2
1Acaster Lloyd Consulting Ltd, London, WC1X 8NL, UK.
Journal of comparative effectiveness research
|January 16, 2024
概括
这项研究量化了非酒精性脂肪肝炎 (NASH) 的健康实用值,发现即使在纤维化早期,生活质量也会下降. 这些发现挑战了先前的假设,并为NASH治疗的经济评估提供了信息.
科学领域:
- 肝病学和胃肠道学
- 卫生经济学 卫生经济学
- 生活质量研究 研究 生命质量研究
背景情况:
- 非酒精性脂肪肝炎 (NASH) 是一个越来越严重的健康问题.
- 以前的研究往往假定在NASH早期阶段没有生活质量差异.
- 准确的效用值对于经济评估至关重要.
研究的目的:
- 为了估计非酒精性脂肪肝炎 (NASH) 的功用值.
- 评估纤维化进展对NASH患者健康相关生活质量的影响.
- 挑战NASH早期生命质量恒定的假设.
主要方法:
- 使用离散选择实验 (DCE) 来评估纤维化进展.
- 向NASH患者和公众提供EQ-5D-5L问卷.
- 使用边际替代率来计算公用事业变化.
主要成果:
- DCE调查包括520名英国普通公众参与者和154名NASH患者.
- 在纤维化阶段F1和F4 (未补偿) 之间估计的效用下降幅度从-0.521到-0.646.
- 结果表明,实用值对纤维化进展,包括早期阶段的敏感性.
结论:
- 三种不同的方法证实,随着NASH的纤维化进展,效用值会下降.
- 该研究强调,即使在NASH的早期,通常是无症状的阶段,生活质量也会受到影响.
- 这些发现需要对NASH干预措施的经济模型进行重新评估.
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
107
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
107
01:09Decision Making: P-value Method
5.4K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
5.4K